M
Massimo Federico
Researcher at University of Modena and Reggio Emilia
Publications - 477
Citations - 24386
Massimo Federico is an academic researcher from University of Modena and Reggio Emilia. The author has contributed to research in topics: Population & Follicular lymphoma. The author has an hindex of 63, co-authored 455 publications receiving 21371 citations. Previous affiliations of Massimo Federico include Casa Sollievo della Sofferenza & University of Pavia.
Papers
More filters
Journal ArticleDOI
Revised response criteria for malignant lymphoma
Bruce D. Cheson,Beate Pfistner,Malik E. Juweid,Randy D. Gascoyne,Lena Specht,Sandra J. Horning,Bertrand Coiffier,Richard I. Fisher,Anton Hagenbeek,Emanuele Zucca,Steven T. Rosen,Sigrid Stroobants,T. Andrew Lister,Richard T. Hoppe,Martin Dreyling,Kensei Tobinai,Julie M. Vose,Joseph M. Connors,Massimo Federico,Volker Diehl +19 more
TL;DR: New guidelines incorporating PET, IHC, and flow cytometry for definitions of response in non-Hodgkin's and Hodgkin's lymphoma are presented and it is hoped that they will be adopted widely by study groups, pharmaceutical and biotechnology companies, and regulatory agencies to facilitate the development of new and more effective therapies to improve the outcome of patients with lymphoma.
Journal ArticleDOI
Follicular lymphoma international prognostic index.
Philippe Solal-Celigny,Pascal Roy,Philippe Colombat,J. M. White,James Olen Armitage,Reyes Arranz-Saez,Wing Yan Au,Monica Bellei,Pauline Brice,Dolores Caballero,Bertrand Coiffier,Eulogio Conde-Garcia,Chantal Doyen,Massimo Federico,Richard I. Fisher,Javier García-Conde,Cesare Guglielmi,Anton Hagenbeek,Corinne Haioun,Michael LeBlanc,Andrew Lister,Armando López-Guillermo,Peter McLaughlin,Noel Milpied,Pierre Morel,Nicolas Mounier,Stephen J. Proctor,Ama Z. S. Rohatiner,Paul Smith,Pierre Soubeyran,Hervé Tilly,Umberto Vitolo,Pier Luigi Zinzani,Emanuele Zucca,Emili Montserrat +34 more
TL;DR: The Follicular Lymphoma International Prognostic Index was designed from the data recorded over 8 years of nearly 5000 patients registered worldwide to help provide an optimal treatment option for patients with follicular lymphoma.
Journal ArticleDOI
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.
Francesco Sardanelli,Carla Boetes,Bettina Borisch,Thomas Decker,Massimo Federico,Fiona J. Gilbert,Thomas H. Helbich,S H Heywang-Köbrunner,Werner A. Kaiser,Michael J. Kerin,Robert E. Mansel,Lorenza Marotti,L. Martincich,L. Mauriac,Hanne Meijers-Heijboer,Roberto Orecchia,Pietro Panizza,Antonio Ponti,Arnie Purushotham,Peter Regitnig,Marco Rosselli Del Turco,Fabienne Thibault,Robin Wilson +22 more
TL;DR: The working group strongly suggests that all breast cancer specialists cooperate for an optimal clinical use of this emerging technology and for future research, focusing on patient outcome as primary end-point.
Journal ArticleDOI
Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts
Heikki Joensuu,Aki Vehtari,Jaakko Riihimäki,Toshirou Nishida,Sonja E. Steigen,Peter Brabec,Lukáš Plank,Bengt Nilsson,Claudia Cirilli,Chiara Braconi,Andrea Bordoni,Magnus K. Magnusson,Zdenek Linke,Jozef Sufliarsky,Massimo Federico,Jon G. Jonasson,Angelo Paolo Dei Tos,Piotr Rutkowski +17 more
TL;DR: Although the modified NIH classification is the best criteria to identify a single high-risk group for consideration of adjuvant therapy, the prognostic contour maps resulting from non-linear modelling are appropriate for estimation of individualised outcomes.
Journal ArticleDOI
Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
Massimo Federico,Monica Bellei,Luigi Marcheselli,Stefano Luminari,Armando López-Guillermo,Umberto Vitolo,Barbara Pro,Stefano Pileri,Alessandro Pulsoni,Pierre Soubeyran,Sergio Cortelazzo,Giovanni Martinelli,Maurizio Martelli,Luigi Rigacci,Luca Arcaini,Francesco Di Raimondo,Francesco Merli,Elena Sabattini,Peter McLaughlin,Philippe Solal-Celigny +19 more
TL;DR: Follicular Lymphoma International Prognostic Index 2 is a simple prognostic index based on easily available clinical data and may represent a promising new tool for the identification of patients with FL at different risk in the era of immunochemotherapy.